Lilly’s Zepbound Keeps Weight Off for Three Years, Study Finds
This article is for subscribers only.
Patients regularly taking Eli Lilly & Co.’s obesity shot Zepbound tend to keep the weight off for at least three years, with most regaining 5% or less of the pounds they shed.
A company-funded study found patients hit their lowest weight in just under two years on average. They gained roughly 3.7% of it back over the following 18 months, according a new analysis of 690 patients to be presented next month at the European Congress on Obesity in Spain.